Reports for ASPEN PHARMACARE CANADA INC.

Company Name

ASPEN PHARMACARE CANADA INC.

Totals

Shortage reports

188

Actual shortage: 9 (5%)
Anticipated shortage: 14 (7%)
Avoided shortage: 33 (18%)
Resolved: 132 (70%)

Discontinuation Reports

2

To be discontinued: 0 (0%)
Discontinued: 2 (100%)
Reversed: 0 (0%)

Late reports

16 (8%)

Overdue reports

4 (17%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EMLA CREAM 2.5% 2.5% CREAM Anticipated shortage 2024-03-18 2024-04-30 222665
XYLOCAINE 2% WITH EPINEPHRINE 1:200000 0.005MG 20MG SOLUTION Anticipated shortage 2024-02-28 2024-04-30 220855
XYLOCAINE 2% W EPINEPHRINE 1:200000 5MCG 20MG SOLUTION Anticipated shortage 2024-03-18 2024-04-30 222670
XYLOCAINE 1% W EPINEPHRINE 1:200000 5MCG 10MG SOLUTION Anticipated shortage 2024-03-18 2024-04-30 222673
SENSORCAINE 5MG SOLUTION Anticipated shortage 2024-03-18 2024-04-30 222686
DIPRIVAN 1% 10MG EMULSION Anticipated shortage 2024-03-18 2024-04-30 222695
DIPRIVAN 1% 10MG EMULSION Anticipated shortage 2024-03-18 2024-04-30 222698
SENSORCAINE 2.5MG SOLUTION Actual shortage 2024-04-16 2024-05-02 225255

Showing 181 to 188 of 188

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ELTROXIN 300MCG TABLET Discontinued 2020-04-29 2020-04-29 113481
IMURAN 50MG POWDER FOR SOLUTION Discontinued 2020-11-20 2021-04-08 128667

Showing 1 to 2 of 2